Bird & Bird advises Vitruvian Partners on acquisition of stake in ADA Health

Cate­gory: Venture Capi­tal
9. April 2019

Frank­furt am Main — Bird & Bird LLP has advi­sed Euro­pean private equity firm Vitru­vian Part­ners on its invest­ment in AI-powered health­care plat­form ADA Health.

Vitru­vian is an inde­pen­dent invest­ment fund head­quar­te­red in London that invests in Euro­pean compa­nies with high growth poten­tial, prima­rily through a focus on tech­no­logy and digi­­ta­­li­za­­tion-based busi­ness models. ADA Health, Europe’s “Hottest Health Start-up 2018,” offers the world’s leading health app, “Ada,” which iden­ti­fies appro­priate next steps for poten­tial proper medi­cal treat­ment for users, as well as B2B users such as health insu­r­ers and health­care provi­ders. The ADA app is AI-powered; it has been available for down­load world­wide since 2016 and has so far ranked first in the medi­cal app space in over 130 countries.

Vitru­vian has inves­ted in ADA Health through a Series B Growth Finan­cing to provide addi­tio­nal growth capi­tal to the company, along with its foun­ding share­hol­ders and exis­ting inves­tors, inclu­ding through a capi­tal raise. This is inten­ded not only to further expand ADA Health’s exis­ting market posi­tion in Germany, but also to enable further roll-out internationally.

The tran­sac­tion has alre­ady been comple­ted. The parties have agreed not to disc­lose the size of the growth investment.

Vitru­vian Part­ners was advi­sed by the follo­wing Bird & Bird attor­neys: Part­ner Dr. Hans Peter Leube, LL.M., Lead, and Asso­cia­tes Mari­anne Nawroth, Dr. Ann-Kris­­tin Asmuß (all Corporate/M&A, Frank­furt) and Inga Kerner (Corporate/M&A, Munich), Part­ner Dr. Fabian Niemann and Asso­ciate Dr. Nils Lölfing (both IT and Data Protec­tion, Düssel­dorf), Coun­sel Lea Mackert, LL.M. and Asso­ciate Dr. Juliane Kliesch (both IT and Commer­cial, Düssel­dorf), Part­ner Dr. Alex­an­der Csaki and Coun­sel Chris­tian Linden­thal, LL.M. (both Health­care Regu­la­tion, Munich), Part­ner Dr. Barbara Geck (Labor Law, Frank­furt) and Asso­ciate Florian Keßenich (Labor Law, Hamburg).


This advice demons­tra­tes once again that Bird & Bird’s parti­cu­lar expe­ri­ence in the tech­no­logy sector is meeting with strong and growing demand in the legal market, and incre­asingly so in private equity advice. This is because the firm is excep­tio­nally well posi­tio­ned, parti­cu­larly in this area, when it comes to advi­sing on invest­ments in compa­nies where data and data protec­tion, regu­la­tion and digi­ta­liza­tion issues play a major role and which ther­eby achieve a signi­fi­cant inno­va­tion boost for the respec­tive indus­try. Peter Leube has alre­ady advi­sed Vitru­vian on seve­ral tran­sac­tions and refi­nan­cings in the health and health­care sector, among others, such as the part­ner­ship with the doctari group.

For press inqui­ries, please contact:
Carola Rehs, Head of Marke­ting and Busi­ness Deve­lo­p­ment Germany
T: +49 (0)211 2005 6243, Email: [email protected]

Notes for the editor
Bird & Bird is an inter­na­tio­nal law firm that advi­ses in parti­cu­lar compa­nies and insti­tu­ti­ons that are shaping and being chan­ged by new tech­no­lo­gies and digi­ta­liza­tion. We combine world-class legal exper­tise with deep indus­try know­ledge and a refres­hin­gly crea­tive mind­set to help clients achieve their busi­ness goals. We have over 1,300 lawy­ers in 29 offices in Europe, the Middle East, Asia Paci­fic and North America, and main­tain close rela­ti­onships with law firms in other parts of the world. To learn more about us, visit

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at]